Dr. Mitchell Machtay, MD

  • Hershey, PA
  • Radiation oncologist
NPI1528081437PAC ID6305732470
Medicare services, 2024
172
Medicare patients, 2024
35
Part D claims, 2024
140
Publications
122
MIPS score, 2024
79
Practice address
500 University Drive, Hershey, PA 17033
Practice phone
Call (717) 531-8521
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

See all 5 affiliations

Find Dr. Machtay's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Mitchell Machtay is a radiation oncologist in Hershey, Pennsylvania

Dr. Machtay practices at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State.

Dr. Machtay's NPI, 1528081437, was assigned on July 25, 2006. Dr. Machtay graduated from New York University School of Medicine in 1989. Dr. Machtay holds Pennsylvania license MD-045031-L.

NPI and contact details
Medicare PAC ID
6305732470
NPI enumeration date
July 25, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(717) 531-8521
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
63
Medical school graduation
1989

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Mitchell Machtay practices at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania

Dr. Machtay's primary practice is Penn State Health Milton S. Hershey Medical Center, at 500 University Drive, Hershey, PA 17033 in Dauphin County. The practice phone is (717) 531-8521.

Source: Dmand AI Affiliation Data

Dr. Mitchell Machtay is affiliated with 2 sites of care and 3 medical groups

Dr. Machtay's primary practice is Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State. Dr. Machtay is also affiliated with Penn State Health Holy Spirit Medical Center. The medical group on file is Penn State Health Milton S. Hershey Medical Center. Dmand AI also links Dr. Machtay to 2 more medical groups, each named with a free account.

See all 5 affiliations for Dr. Machtay

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Mitchell Machtay's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Machtay practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Penn State Health Milton S. Hershey Medical CenterAvailable with a free account
+1 more site and 2 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Machtay practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Penn State and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Mitchell Machtay is one of 304 radiation oncologists in Pennsylvania

Radiation oncology is Dr. Machtay's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Machtay's licenses on file in 2 states: Pennsylvania and Ohio.

Specialties and state licenses

  • Radiation oncology, PennsylvaniaPrimaryLicense MD-045031-L · taxonomy 2085R0001X
  • Ohio licenseLicense 35-094475

Radiation oncologists near Dr. Machtay

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Mitchell Machtay billed Medicare for 172 services in 2024

CMS data shows 172 Medicare services from Dr. Machtay across 4 procedure codes in 2024, for 35 Medicare patients. Medicare paid $8,938 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024172
Medicare patients35
Paid by Medicare$8,938
Procedure codes4

Dr. Machtay's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 5392024: 17268%
Office and hospital visits
2023: 112024: 0100%

Dr. Machtay compared with the Pennsylvania median for radiation oncologists, 2024

  • Dr. Machtay
  • Pennsylvania median
Medicare services
172vs 1,02783% below
Medicare patients
35vs 16078% below
Part D claims
81vs 392.1 times

Medians across 308 radiation oncologists in Pennsylvania with Dmand AI profiles that report each measure.

Dr. Machtay's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Machtay

Need commercial claims for Dr. Machtay?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Machtay and other radiation oncologists in Pennsylvania.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Mitchell Machtay treated 35 Medicare patients in 2024, average age 74

CMS counts 35 Medicare patients who saw Dr. Machtay in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Machtay's median patient age at 74, with 46% women.

Medicare patients, 202435
Average age74
Average risk score2.33

Dr. Machtay's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Machtay's Medicare patients by sex, 2024

  • Women1337%
  • Men2263%

Chronic conditions among Dr. Machtay's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Ischemic heart disease43%
  5. Arthritis40%
  6. Anxiety34%
  7. Depression34%
  8. Mood disorders34%

Share of Medicare patients with each condition. A patient can have several.

Dr. Machtay's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 74

Patient panel by sex, all payers

  • Women46%
  • Men54%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Mitchell Machtay wrote 140 Medicare Part D claims in 2024

In 2024, Dr. Machtay wrote 140 Medicare Part D claims for 37 patients. 95% of them were for generic drugs. CMS names the drug for 81 of them, across 5 drugs with 11 or more claims each, at $1,528 in total drug cost. In 2023, CMS named 45 claims across 3 drugs.

Part D claims, 2024140
Drugs named by CMS5
Total drug cost$1,528
Part D patients37

Dr. Machtay's Part D claims by kind of drug, 2024

  • Generic133 claims95%
  • Brand-name and other7 claims5%

Dr. Machtay's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 452024: 8180%

Drugs named by CMS: 5 in 2024, 3 in 2023.

See all prescribing by Dr. Machtay

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Mitchell Machtay scored 79 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Machtay for performance year 2024, reported as part of a group. Dr. Machtay accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Machtay's MIPS scores, performance year 2024

  • 79of 100Final score
  • 56.7of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 75of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find radiation oncologists like Dr. Machtay by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Mitchell Machtay has 122 publications on record

Dmand AI links 122 papers to Dr. Machtay, published from 2011 to 2025. 2021 was the busiest year, with 11. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Chemoradiotherapy. Dr. Machtay has published most often in Int J Radiat Oncol Biol Phys. Dr. Machtay's most frequent co-authors are Tithi Biswas, MD, Rodney Jay Ellis, MD and Musaddiq Javvad Awan, MD.

Papers122
Years published2011 to 2025

Dr. Machtay's papers by year, 2016 to 2025

Topics Dr. Machtay writes about most

  • Lung Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Chemoradiotherapy
  • Head and Neck Neoplasms
  • Dose Fractionation, Radiation
  • Radiosurgery
  • Brain Neoplasms
  • Radiotherapy Dosage

Dr. Machtay's most frequent co-authors

Recent publications by Dr. Machtay

See all 122 publications and co-authors

See who Dr. Machtay researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Machtay works with, so you can find a warm path to the right radiation oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Mitchell Machtay received $5,326 in industry payments from 2016 to 2025

CMS Open Payments shows 25 general payments to Dr. Machtay from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 43% of the total. AstraZeneca Pharmaceuticals LP paid the most, $3,348.

General payments to Dr. Machtay by program year, 2016 to 2025

General payments to Dr. Machtay by kind, 2016 to 2025

$5.3Kin total
  • Consulting fees$2,26543%
  • Travel and lodging$2,01838%
  • Food and beverage$1,02719%
  • Education$170%

Companies that paid Dr. Machtay the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Machtay

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Mitchell Machtay graduated from New York University School of Medicine

Dr. Machtay graduated from New York University School of Medicine in 1989.

  1. Medical schoolNew York University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Mitchell Machtay's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Mitchell Machtay

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Mitchell Machtay's NPI number?

Dr. Mitchell Machtay's NPI number is 1528081437. It was assigned on July 25, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Mitchell Machtay?

Dr. Mitchell Machtay is a radiation oncologist in Hershey, Pennsylvania. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Mitchell Machtay practice?

Dr. Machtay practices at 500 University Drive, Hershey, PA 17033. Dr. Machtay's primary practice is Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania, part of Penn State. Dmand AI also links Dr. Machtay to 2 medical groups.

What is Dr. Mitchell Machtay's office phone number?

The practice phone on file for Dr. Machtay is (717) 531-8521.

What is Dr. Mitchell Machtay's medical license number?

Dr. Machtay holds Pennsylvania license MD-045031-L, one of the licenses on file in 2 states.

Which states has Dr. Mitchell Machtay been licensed in?

Dmand AI has state licenses on file for Dr. Machtay in Pennsylvania and Ohio.

Which hospitals is Dr. Mitchell Machtay affiliated with?

Dr. Machtay practices at Penn State Health Milton S. Hershey Medical Center in Hershey, Pennsylvania. Dr. Machtay is also affiliated with Penn State Health Holy Spirit Medical Center.

What medical group is Dr. Mitchell Machtay part of?

Dr. Machtay is linked to Penn State Health Milton S. Hershey Medical Center. Dmand AI links Dr. Machtay to 2 more medical groups.

Does Dr. Mitchell Machtay accept Medicare?

Yes. CMS data shows Dr. Machtay billed Medicare for 172 services in 2024, and Dr. Machtay accepts Medicare assignment.

What is Dr. Mitchell Machtay's MIPS score?

Dr. Machtay's MIPS final score for performance year 2024 is 79 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. Mitchell Machtay see?

CMS counts 35 Medicare patients who saw Dr. Machtay in 2024, with an average age of 74.

What services does Dr. Mitchell Machtay bill to Medicare?

In 2024, Dr. Machtay's most billed Medicare services were radiation oncology (77300), radiation oncology (77334) and radiation oncology (77263).

Where did Dr. Mitchell Machtay go to medical school?

Dr. Machtay graduated from New York University School of Medicine in 1989.

What drugs does Dr. Mitchell Machtay prescribe most?

In 2024 Medicare Part D data, Dr. Machtay's most prescribed drugs by claims were Lidocaine HCl Viscous, Albuterol Sulfate Hfa and Famotidine.

Has Dr. Mitchell Machtay received payments from drug or device companies?

CMS Open Payments shows $5,326 in general payments to Dr. Machtay from 11 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Mitchell Machtay been practicing?

Dr. Machtay graduated from medical school in 1989, 37 years ago.

Does Dr. Mitchell Machtay do research?

Dmand AI links 122 publications to Dr. Machtay, published from 2011 to 2025.

Who does Dr. Mitchell Machtay publish with?

Dr. Machtay's most frequent co-authors are Tithi Biswas, MD (20 shared papers), Rodney Jay Ellis, MD (17 shared papers) and Musaddiq Javvad Awan, MD (11 shared papers).

Selling to radiation oncology practices?

See radiation oncologists in Pennsylvania by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)